What Symptoms Indicate Low Testosterone in Men?

← Back to Clinical Articles

Article: What Symptoms Indicate Low Testosterone in Men?  |  Category: Hormone  |  Authored by: Brian Lamkin, DO

The Symptom Cluster That Gets Misdiagnosed

A 42-year-old man comes in and says: "I am tired all the time. I have no interest in sex. I am gaining weight around my midsection no matter what I do. I cannot focus at work the way I used to. I feel irritable for no reason. I used to recover from workouts in a day and now it takes three." His primary care physician prescribed an SSRI for depression and told him his tiredness was from stress. These symptoms are not depression. They are not stress. They are the clinical presentation of testosterone deficiency, and they appear together because testosterone influences every system they describe. The symptom cluster is specific, recognizable, and measurable.

The Natural Rate of Decline

Testosterone in men peaks in the late teens to mid-twenties and begins declining approximately 1 to 2 percent per year after age 30^[1]. By age 50, a man has lost 20 to 40 percent of his peak testosterone. By age 60, the loss may exceed 50 percent. This decline is real and physiological, but the rate varies dramatically. Metabolically healthy men who sleep well, maintain muscle mass, manage stress, and avoid visceral fat accumulation decline slowly. Men with insulin resistance, poor sleep, chronic stress, sedentary lifestyle, and excess visceral fat decline much faster. A metabolically healthy 55-year-old may have testosterone equivalent to an average 35-year-old. A metabolically compromised 40-year-old may have testosterone equivalent to an average 65-year-old.

Fatigue: Not Enough Sleep or Not Enough Testosterone?

Testosterone-related fatigue is distinct from sleep deprivation fatigue. It manifests as a pervasive lack of physical and mental energy that persists despite adequate sleep. Patients describe it as feeling like they are operating at 60 percent capacity. The physiological mechanism: testosterone influences mitochondrial function, red blood cell production (and therefore oxygen-carrying capacity), and glucose metabolism. Deficiency produces reduced cellular energy output, mild anemia (often subclinical), and impaired glucose utilization. The fatigue is present upon waking, worsens through the day, and does not resolve with rest. If a man is sleeping 7 to 8 hours and still feels exhausted, testosterone evaluation is warranted.

Reduced Libido and Loss of Morning Erections

Libido (sexual desire) and erectile function are among the most testosterone-sensitive functions. Testosterone drives sexual interest through hypothalamic signaling and maintains erectile function through nitric oxide production in the corpus cavernosum^[2]. Morning erections (nocturnal penile tumescence) are a physiological marker of adequate testosterone and vascular health. Their absence, or marked reduction in frequency and rigidity, is one of the earliest and most specific signs of declining testosterone. Reduced libido is frequently dismissed as "just getting older" or attributed to relationship dynamics. When it appears alongside the other symptoms in this cluster, it is a hormonal signal, not a psychological one.

Visceral Weight Gain and Body Composition Shift

Testosterone regulates fat distribution and muscle mass in men. Deficiency produces a characteristic body composition shift: muscle mass decreases while visceral fat increases, particularly around the abdomen. The mechanism is direct: testosterone inhibits lipogenesis in visceral fat cells and stimulates lipolysis. When testosterone drops, visceral fat expands. Simultaneously, reduced testosterone means reduced anabolic drive for muscle protein synthesis, so muscle mass declines. The patient gains weight around the midsection while losing muscle tone in the arms, chest, and legs. This shift occurs even without changes in diet or activity. It is a hormonal redistribution, not a caloric one. Visceral fat itself then produces aromatase, converting remaining testosterone to estradiol, which further suppresses testosterone in a self-reinforcing cycle.

Brain Fog and Cognitive Changes

Testosterone receptors are densely expressed in the hippocampus and prefrontal cortex. Deficiency produces measurable cognitive changes: difficulty with verbal fluency, reduced working memory, impaired concentration, and a subjective sense of mental slowness that patients describe as "brain fog." These changes are often the symptom that brings men to seek evaluation because they interfere with work performance. The cognitive effects of low testosterone overlap significantly with the symptoms of depression, which is why low testosterone is frequently misdiagnosed as major depressive disorder. The distinction matters because SSRIs do not treat testosterone deficiency, and some SSRIs can further suppress testosterone and libido.

Mood Changes: Irritability, Not Sadness

The mood signature of low testosterone in men is irritability, not sadness^[3]. Men with declining testosterone frequently describe a shorter fuse, reduced patience, disproportionate reactions to minor stressors, and a general sense of dissatisfaction or apathy. This is often misinterpreted as a personality change or attributed to external circumstances ("work stress," "midlife crisis"). The mechanism involves testosterone's influence on serotonergic and dopaminergic signaling. When testosterone drops, the neurotransmitter milieu shifts in ways that reduce stress tolerance and emotional regulation. Testosterone replacement in deficient men consistently improves mood, reduces irritability, and restores a sense of well-being that patients describe as "feeling like myself again."

Poor Exercise Recovery and Reduced Physical Performance

Testosterone is the primary anabolic hormone driving muscle protein synthesis, glycogen replenishment, and tissue repair after exercise. Men with declining testosterone notice that workouts that previously produced strength gains now produce soreness without improvement. Recovery time extends from one day to two or three. The ability to build or even maintain muscle diminishes despite continued training. Strength plateaus or declines. Endurance decreases. The training stimulus that maintained their body composition through their 30s is no longer sufficient. This is frequently attributed to "aging" when the actual driver is hormonal.

Sleep Disruption

Low testosterone contributes to sleep disruption through several mechanisms. It reduces sleep efficiency (time asleep versus time in bed), increases nocturnal awakenings, and may contribute to sleep apnea severity through its relationship with body composition. Simultaneously, poor sleep further reduces testosterone production, creating a bidirectional cycle. Men who begin experiencing fragmented sleep alongside the other symptoms in this cluster should have both testosterone and cortisol rhythm evaluated, as cortisol dysregulation (elevated evening cortisol) is a common concurrent finding.

The Mimics: What Else Looks Like Low Testosterone

Several conditions produce overlapping symptoms and must be evaluated alongside testosterone. Hypothyroidism produces fatigue, weight gain, brain fog, and reduced libido. Cortisol dysregulation produces fatigue, visceral fat, irritability, and poor recovery. Insulin resistance produces fatigue, visceral weight gain, and brain fog. Iron deficiency produces fatigue and reduced exercise tolerance. Vitamin D deficiency produces fatigue and mood changes. Vitamin D below 50 ng/mL is independently associated with lower testosterone. This is why comprehensive evaluation includes the full hormone network, not just testosterone. A man whose fatigue is driven by subclinical hypothyroidism will not improve with testosterone therapy alone. A man whose low testosterone is driven by insulin resistance may restore his testosterone by addressing the metabolic root cause.

The Evaluation That Actually Identifies the Problem

Comprehensive evaluation includes total testosterone (drawn fasting before 10 AM), free testosterone^[4] (calculated from total testosterone and SHBG or by equilibrium dialysis), SHBG, estradiol (to assess aromatase conversion), DHEA-S, LH and FSH (to distinguish primary from secondary hypogonadism), prolactin, full thyroid panel (TSH, Free T3, Reverse T3, TPO antibodies), 4-point cortisol, fasting insulin and HOMA-IR, and vitamin D. Each marker evaluates a different node in the network and identifies whether the problem is testosterone production, binding, conversion, or a concurrent driver that mimics or worsens the deficit.

The Lamkin Clinic Approach

Every male hormone evaluation at The Lamkin Clinic begins with the full panel described above. The results determine the intervention. If the problem is lifestyle-reversible (poor sleep, insulin resistance, visceral adiposity, stress), we sequence natural optimization first: sleep architecture, resistance training, dietary structure, stress management, and nutrient repletion. If the problem is structural (primary hypogonadism with elevated LH and FSH, or secondary hypogonadism with identified pituitary or hypothalamic dysfunction), bioidentical testosterone replacement is initiated on top of the lifestyle foundation. In both cases, the full evaluation prevents treating the wrong driver and ensures that concurrent conditions (thyroid, cortisol, insulin) are addressed alongside testosterone.

The Lamkin Clinic, Edmond Oklahoma | lamkinclinic.com

Frequently Asked Questions

Related Conditions

Related Clinical Articles

References and Further Reading

1. [1]Harman SM, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab. 2001;86(2):724-731.
2. [2]Mulhall JP, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432.
3. [3]Walther A, et al. Association of testosterone treatment with alleviation of depressive symptoms in men: a systematic review and meta-analysis. JAMA Psychiatry. 2019;76(1):31-40.
4. [4]Vermeulen A, et al. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666-3672.